METHOD OF SEPSIS THERAPY IN NEWBORNS

摘要

FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to neonatology, and can be used for sepsis prevention in newborns. That is ensured by the pre-assay of lymphocytes of late apoptosis in baby's venous blood by flow cytofluorometry technique. If the determined value exceeds 0.56%, the intensive therapy applied is added with the intravenous introduction human recombinant granulocytic colony-stimulating factor (hr-GCSF) in a daily dose 10 mcg/kg. The period of treatment is 3 days. ^ EFFECT: invention enables well-timed pathogenetic therapy at the preclinical stage with intensifying the intensive therapy applied that promotes lower neonatal sepsis related lethality. ^ 3 ex